BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Policy

  Tomocube Microscope advances Malaria Research

  Label-free, 3-D holotomography imaging enables researchers to observe morphological and chemical alterations of host cells without transfection or dye staining

  August 14, 2019

   · 

  4 min read
• 

  BioSpace Global Roundup, Aug. 15

  Biopharma companies from across the globe provide updates on their pipeline and business.

  August 14, 2019

   · 

  6 min read

   · 

  Alex Keown
• 

  Policy

  After Two Phase III Successes, Calquence Earns Breakthrough Therapy Designation

  The new designation granted to Calquence marks the 10th such designation the company has earned since 2014, AstraZeneca said.

  August 14, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  BioCapital

  IBD-Focused Landos Biopharma Secures $60 Million in Financing

  Landos said the funds will be used to advance its lead asset, BT-11, into global Phase II clinical trials for ulcerative colitis and Crohn’s disease.

  August 14, 2019

   · 

  2 min read

   · 

  Alex Keown
• Pharma specialist opts for BioPure products to optimise hermetic sealing

  S3 Process, an OEM specialising in process equipment for the pharmaceutical industry, is using BioPure BioClamp® and BioPure silicone gasket technology on its new PuroVaso® containers, for the effective handling of powders and tablets in life science applications.

  August 14, 2019

   · 

  2 min read
• Kadans Science Partner Invests in Stevenage UK Enabling Future Growth of the Research & Development Base

  Kadans expands its presence in the United Kingdom by adding its second research hub in the country to its Pan-European science park portfolio.

  August 14, 2019

   · 

  1 min read
• Business

  AC Immune Reports Q2 2019 Financial Results, Business and Clinical Update

  Company Outlines Roadmap to Develop Successful Therapies for Neurodegenerative Diseases Based on its Broad Anti-Tau Clinical Pipeline

  August 14, 2019

   · 

  8 min read
• 

  Drug Development

  Regeneron’s Evinacumab Effective in Treating Rare, Inherited High-Cholesterol Disease

  In the trial, evinacumab showed a 49% decrease in LDL cholesterol from baseline compared to placebo, which showed a 2% increase.

  August 14, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  BioCapital

  D&D Pharmatech’s $137.1 Million Series B to Support Clinical Trials in Alzheimer’s, Parkinson’s and Fibrosis

  D&D Pharmatech is the parent company of U.S.-based Neuraly, Precision Molecular and Theraly Fibrosis. All three are spinouts from Johns Hopkins School of Medicine.

  August 14, 2019

   · 

  3 min read

   · 

  Mark Terry
• Pharm Country

  Booming Breakthrough: Creative Biolabs Enables World’s First 100% Identification of Leucine and Isoleucine in De Novo Antibody Sequencing

  It has long been a worldwide problem to precisely identify leucine and isoleucine, not to mention 100% accuracy.

  August 14, 2019

   · 

  4 min read